secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lipocine Inc. (LPCN)
CIK:        0001535955
Form:       8-K
Filed at:   2026-09-11T10:10:33+00:00
Accession:  0001493152-26-042286
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Lipocine raises ATM sales agent fee to up to 3.0% under 2024 agreement
----------------------------------------------------------------------

- On Sept 8, 2026, Lipocine and A.G.P./Alliance Global Partners agreed the Sales Agent fee under the April 26, 2024 Sales Agreement will be up to 3.0%.
- Fee is subject to adjustment by mutual consent; replaces prior fee terms under the same ATM agreement.
- No offering size, proceeds, or timeline disclosed in this filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1535955/000149315226042286/0001493152-26-042286-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1535955/000149315226042286/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-042286

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer